Literature DB >> 20868877

Epidemiology of the cerebral palsies.

Eve Blair1.   

Abstract

Half of the most severe cases of cerebral palsy (CP) survive to adulthood, but because this longevity is relatively recent, there is no empirical experience of their life expectancy past middle age. The last 2 decades have seen significant developments in the management of persons with CP, involving specialist services from an increasing number of disciplines that require coordination to maximize their effectiveness. This article provides an overview of CP. The author discusses definitions of CP, its epidemiology, pathologies, and range of possible clinical descriptions, and briefly touches on management and prevention.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20868877     DOI: 10.1016/j.ocl.2010.06.004

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  17 in total

1.  Trends in the prevalence of cerebral palsy among very preterm infants (<31 weeks' gestational age).

Authors:  Michael J Vincer; Alexander C Allen; Victoria M Allen; Thomas F Baskett; Colleen M O'Connell
Journal:  Paediatr Child Health       Date:  2014-04       Impact factor: 2.253

2.  The cerebral palsy research registry: development and progress toward national collaboration in the United States.

Authors:  Donna S Hurley; Theresa Sukal-Moulton; Michael E Msall; Deborah Gaebler-Spira; Kristin J Krosschell; Julius P Dewald
Journal:  J Child Neurol       Date:  2011-06-15       Impact factor: 1.987

3.  Spinal cord injury in hypertonic newborns after antenatal hypoxia-ischemia in a rabbit model of cerebral palsy.

Authors:  Alexander Drobyshevsky; Katharina A Quinlan
Journal:  Exp Neurol       Date:  2017-03-24       Impact factor: 5.330

4.  Autism spectrum disorder, ADHD, epilepsy, and cerebral palsy in Norwegian children.

Authors:  Pål Surén; Inger Johanne Bakken; Heidi Aase; Richard Chin; Nina Gunnes; Kari Kveim Lie; Per Magnus; Ted Reichborn-Kjennerud; Synnve Schjølberg; Anne-Siri Øyen; Camilla Stoltenberg
Journal:  Pediatrics       Date:  2012-06-18       Impact factor: 7.124

Review 5.  Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy.

Authors:  Francesco C Blumetti; João Carlos Belloti; Marcel Js Tamaoki; José A Pinto
Journal:  Cochrane Database Syst Rev       Date:  2019-10-08

Review 6.  A review of environmental contributions to childhood motor skills.

Authors:  Jean Golding; Pauline Emmett; Yasmin Iles-Caven; Colin Steer; Raghu Lingam
Journal:  J Child Neurol       Date:  2013-10-29       Impact factor: 1.987

Review 7.  Valid and reliable instruments for arm-hand assessment at ICF activity level in persons with hemiplegia: a systematic review.

Authors:  Ryanne J M Lemmens; Annick A A Timmermans; Yvonne J M Janssen-Potten; Rob J E M Smeets; Henk A M Seelen
Journal:  BMC Neurol       Date:  2012-04-12       Impact factor: 2.474

8.  Effects of Neuromuscular Electrical Stimulation on the Masticatory Muscles and Physiologic Sleep Variables in Adults with Cerebral Palsy: A Novel Therapeutic Approach.

Authors:  Lilian Chrystiane Giannasi; Miriam Yumi Matsui; Sandra Regina Batista Freitas; Bruna F Caldas; Eduardo Grossmann; José Benedito O Amorim; Israel Dos Reis dos Santos; Luis Vicente Franco Oliveira; Claudia Santos Oliveira; Monica Fernandes Gomes
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

9.  Associations between Manual Abilities, Gross Motor Function, Epilepsy, and Mental Capacity in Children with Cerebral Palsy.

Authors:  Ewa Gajewska; Magdalena Sobieska; Włodzimierz Samborski
Journal:  Iran J Child Neurol       Date:  2014

10.  Effectiveness of Constraint induced movement therapy as compared to bimanual therapy in Upper motor function outcome in child with hemiplegic Cerebral palsy.

Authors:  Hira Zafer; Imran Amjad; Arshad Nawaz Malik; Enfall Shaukat
Journal:  Pak J Med Sci       Date:  2016 Jan-Feb       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.